Endovascular Engineering, Inc.

About Endovascular Engineering, Inc.

Endovascular Engineering is focused on reimagining endovascular care through innovative technologies. Their mission is to improve patient outcomes by developing advanced medical devices that combine the benefits of small and large-bore systems, reducing risk and enhancing procedural efficiency.

Products & Services

Hēlo™ Thrombectomy System:A system for pulmonary embolism treatment with a small profile for agility and large bore performance. Features include a unique self-expanding funnel design for effective clot engagement, dual-action technology for clot breakdown and removal, and a single-pass catheter for easy navigation in complex anatomies. Currently for investigational use only and not approved for commercial sale.

Specialties

Endovascular Care Thrombectomy Systems Pulmonary Embolism Treatment Medical Device Innovation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 42000000 MR: - FA: $42 million FAN: 42000000	D: 2025-02-18 FD: 2025-02-18	6 investors

Series B Latest

2025-02-18

$42.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Dan Rose

Chief Executive Officer

LinkedIn (Pro only)

M

Mike Rosenthal

Chief Operations Officer

LinkedIn (Pro only)

S

Scott Baron

Chief Technology Officer

LinkedIn (Pro only)

L

Luis Savastano, MD, PhD

Founder, Chief Scientific Officer

T

Thomas Engels

SVP Clinical and Market Development

D

Debra Cogan

VP of Clinical and Regulatory Affairs

View 11 more team members with Pro

Unlock Full Team Directory

Recent News